» Articles » PMID: 2858214

Beta 1-selective and Non-selective Beta-adrenoceptor Blockade, Anaerobic Threshold and Respiratory Gas Exchange During Exercise

Overview
Specialty Pharmacology
Date 1985 Jan 1
PMID 2858214
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of oral doses of the beta 1-selective adrenoceptor antagonist atenolol (50 mg), the non-selective antagonist propranolol (40 mg) and placebo was investigated during exercise in a crossover comparison in six healthy but untrained subjects. Descriptors of ventilation, respiratory gas exchange, and arterialized blood lactate and glucose were obtained during steady state bicycle ergometric exercise at 20% and 60% of the subjects' previously determined maximal oxygen uptake (VO2 max). At these work intensities, the previously reported increase of respiratory exchange ratio (RER) during non-selective beta-adrenoceptor blockade was found to be trivial (placebo = 0.96 +/- 0.03 s.e. mean; propranolol = 0.97 +/- 0.01; atenolol = 0.97 +/- 0.04; 60% VO2 max, 10 min exercise) and only present during the early minutes of effort. Oxygen uptake and carbon dioxide production did not differ between treatments. Both drugs produced highly significant falls in peak expiratory flow (PEF) rates and tidal volume (VT) which were compensated by an increase in respiratory rate. PEF, 60% VO2 max: placebo = 3.8 +/- 0.3 l/s; propranolol 3.6 +/- 0.3 l/s (P less than 0.03); atenolol 3.1 +/- 0.3 l/s (P less than 0.01). VT, 60% VO2 max: placebo 2.0 +/- 0.1 l; propranolol 1.8 +/- 0.21 (P less than 0.05); atenolol 1.7 +/- 0.1 1 (P less than 0.01). Arterialized lactate was significantly elevated during work at 20% and 60% VO2 max, but rose progressively at the 60% VO2 max load. Ventilation, oxygen uptake and ventilatory equivalent for carbon dioxide also rose progressively at this workload. Ventilatory equivalent for oxygen showed no significant rise.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.

van Baak M, Verstappen F, Oosterhuis B Eur J Clin Pharmacol. 1986; 30(4):399-406.

PMID: 3743615 DOI: 10.1007/BF00607951.


Beta-adrenoceptor blockade and exercise. An update.

van Baak M Sports Med. 1988; 5(4):209-25.

PMID: 2897710 DOI: 10.2165/00007256-198805040-00002.


The effects of beta-adrenoceptor blockade on breathing during progressive exercise in normal man.

Pearson S, Morrison J, Simpson F Br J Clin Pharmacol. 1987; 24(2):173-8.

PMID: 2887191 PMC: 1387746. DOI: 10.1111/j.1365-2125.1987.tb03158.x.


Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Wadworth A, Murdoch D, Brogden R Drugs. 1991; 42(3):468-510.

PMID: 1720383 DOI: 10.2165/00003495-199142030-00007.

References
1.
Epstein S, Robinson B, Kahler R, Braunwald E . Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest. 1965; 44(11):1745-53. PMC: 289674. DOI: 10.1172/JCI105282. View

2.
McLeod A, Brown J, Kitchell B, Sedor F, Kuhn C, SHAND D . Hemodynamic and metabolic responses to exercise after adrenoceptor blockade in humans. J Appl Physiol Respir Environ Exerc Physiol. 1984; 56(3):716-22. DOI: 10.1152/jappl.1984.56.3.716. View

3.
LOUBATIERES A, Mariani M, Sorel G, Savi L . The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor. Diabetologia. 1971; 7(3):127-32. DOI: 10.1007/BF01212541. View

4.
Forster H, Dempsey J, Thomson J, Vidruk E, doPico G . Estimation of arterial PO2, PCO2, pH, and lactate from arterialized venous blood. J Appl Physiol. 1972; 32(1):134-7. DOI: 10.1152/jappl.1972.32.1.134. View

5.
STANTON H . Selective metabolic and cardiovascular beta receptor antagonism in the rat. Arch Int Pharmacodyn Ther. 1972; 196(2):246-58. View